sotalol and Dyspnea
sotalol has been researched along with Dyspnea in 3 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Dyspnea: Difficult or labored breathing.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sotalol is an antiarrhythmic agent with combined beta-blocking and class III antiarrhythmic properties." | 6.68 | Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. ( Das, G; Falk, R; Hanyok, JJ; Hardy, SA; Karagounis, L; Platia, E; Sung, RJ; Tan, HL, 1995) |
| "Sotalol is an antiarrhythmic agent with combined beta-blocking and class III antiarrhythmic properties." | 2.68 | Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. ( Das, G; Falk, R; Hanyok, JJ; Hardy, SA; Karagounis, L; Platia, E; Sung, RJ; Tan, HL, 1995) |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Reynolds, MR | 1 |
| Bunch, TJ | 1 |
| Steinberg, BA | 1 |
| Ronk, CJ | 1 |
| Kim, H | 1 |
| Wieloch, M | 1 |
| Lip, GYH | 1 |
| Smith, BG | 1 |
| Oruc, V | 1 |
| Kay, GN | 1 |
| Sung, RJ | 1 |
| Tan, HL | 1 |
| Karagounis, L | 1 |
| Hanyok, JJ | 1 |
| Falk, R | 1 |
| Platia, E | 1 |
| Das, G | 1 |
| Hardy, SA | 1 |
Trials
1 trial available for sotalol and Dyspnea
| Article | Year |
|---|---|
Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
Topics: Adult; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Dose-Response Relationship, | 1995 |
Other Studies
2 other studies available for sotalol and Dyspnea
| Article | Year |
|---|---|
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Dizziness; Dronedarone; Dyspnea; Electronic Heal | 2023 |
Unusual Pacing After Electrical Cardioversion.
Topics: Adrenergic beta-Antagonists; Aged; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Dyspnea; | 2019 |